North America Antivenom Market is expected to reach USD 542.4 million by 2021 from USD 427.6 million in 2016, growing at a CAGR of 4.87% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness ... Read more
